Skip to main content
Closing soon! Submit an IND-enabling/clinical studies grant pre-proposal >>
Hide alert
About Us
History & Overview
Our Team
Research Services
Venture Analysts
Venture Center
Our Partners
Grants
Accelerating Innovation
Technology Commercialization
Postdoctoral Fellowships
Student Programs
Building the Innovation Ecosystem
Submit Phased Grant Pre-Proposal
IND-Enabling/Clinical Studies request for proposals
Planning Grants Request for Applications
Recent Grants
Startup Investments
Investing in Washington
Active Portfolio & Exits
Stories
News
Articles
Videos
Reports
Contact
Close
Keywords:
Search
Toggle Search
Toggle mobile menu
How Sean McClain founded Absci at just 22 — and now leads a newly public biotech worth nearly $2B
Post navigation
←
Absci shares spike 30% in IPO debut, valuing Washington state biotech company at nearly $2B
AdaptX raises $6M, changes name from MDMetrix, expands quest for healthcare data insights
→
Comments are closed.
About Us
History & Overview
Our Team
Research Services
Venture Analysts
Venture Center
Our Partners
Grants
Accelerating Innovation
Technology Commercialization
Postdoctoral Fellowships
Student Programs
Building the Innovation Ecosystem
Submit Phased Grant Pre-Proposal
IND-Enabling/Clinical Studies request for proposals
Planning Grants Request for Applications
Recent Grants
Startup Investments
Investing in Washington
Active Portfolio & Exits
Stories
News
Articles
Videos
Reports
Contact
Close menu